Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George F Atweh

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
American Journal of Hematology|June 1, 2010
Hydroxyurea in sickle cell disease: What will it take to change practice?George F Atweh
Hematology. American Society of Hematology. Education Program|November 25, 2006
Induction of fetal hemoglobin in the treatment of sickle cell diseaseHassana Fathallah, George F Atweh
Blood Reviews|March 4, 2006
DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applicationsHassana Fathallah, George F Atweh
Molecular Cancer Therapeutics|December 19, 2006
Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancerSucharita J Mistry, George F Atweh
Journal of Cellular Biochemistry|September 16, 2004
The role of stathmin in the regulation of the cell cycleCamelia Iancu Rubin, George F Atweh
Current Hematology Reports|March 16, 2006
Prevention and management of strokes in patients with sickle cell diseaseMiguel R Abboud, George F Atweh
The Mount Sinai Journal of Medicine, New York|November 5, 2002
Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapySucharita J Mistry, George F Atweh
The Journal of Clinical Investigation|April 4, 2007
Sickle cell disease: old discoveries, new concepts, and future promisePaul S Frenette, George F Atweh
Trends in Cell Biology|June 14, 2005
p27(Kip1) and stathmin share the stage for the first timeCamelia Iancu-Rubin, George F Atweh
Cell Cycle (Georgetown, Tex.)|December 9, 2014
p27(Kip1) and STMN1: partners again?George F Atweh, Camelia Iancu-Rubin
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
American Journal of Hematology|June 1, 2010
Hydroxyurea in sickle cell disease: What will it take to change practice?George F Atweh
Hematology. American Society of Hematology. Education Program|November 25, 2006
Induction of fetal hemoglobin in the treatment of sickle cell diseaseHassana Fathallah, George F Atweh
Blood Reviews|March 4, 2006
DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applicationsHassana Fathallah, George F Atweh
Molecular Cancer Therapeutics|December 19, 2006
Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancerSucharita J Mistry, George F Atweh
Journal of Cellular Biochemistry|September 16, 2004
The role of stathmin in the regulation of the cell cycleCamelia Iancu Rubin, George F Atweh
Current Hematology Reports|March 16, 2006
Prevention and management of strokes in patients with sickle cell diseaseMiguel R Abboud, George F Atweh
The Mount Sinai Journal of Medicine, New York|November 5, 2002
Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapySucharita J Mistry, George F Atweh
The Journal of Clinical Investigation|April 4, 2007
Sickle cell disease: old discoveries, new concepts, and future promisePaul S Frenette, George F Atweh
Trends in Cell Biology|June 14, 2005
p27(Kip1) and stathmin share the stage for the first timeCamelia Iancu-Rubin, George F Atweh
Cell Cycle (Georgetown, Tex.)|December 9, 2014
p27(Kip1) and STMN1: partners again?George F Atweh, Camelia Iancu-Rubin
Pageof 3